IS4536A - Ný taxóíð, aðferð til framleiðslu þeirra og lyfjasamsetningar sem innihalda þau - Google Patents

Ný taxóíð, aðferð til framleiðslu þeirra og lyfjasamsetningar sem innihalda þau

Info

Publication number
IS4536A
IS4536A IS4536A IS4536A IS4536A IS 4536 A IS4536 A IS 4536A IS 4536 A IS4536 A IS 4536A IS 4536 A IS4536 A IS 4536A IS 4536 A IS4536 A IS 4536A
Authority
IS
Iceland
Prior art keywords
manufacture
pharmaceutical compositions
compositions containing
new taxoids
taxoids
Prior art date
Application number
IS4536A
Other languages
English (en)
Other versions
IS2058B (is
Inventor
Bouchard Hervé
Bourzat Jean-Dominique
Commerçon Alain
Original Assignee
Aventis Pharma S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9503545A external-priority patent/FR2732340B1/fr
Priority claimed from FR9515381A external-priority patent/FR2742754B1/fr
Application filed by Aventis Pharma S.A. filed Critical Aventis Pharma S.A.
Publication of IS4536A publication Critical patent/IS4536A/is
Publication of IS2058B publication Critical patent/IS2058B/is

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
IS4536A 1995-03-27 1997-07-31 Ný taxóíð, aðferð til framleiðslu þeirra og lyfjasamsetningar sem innihalda þau IS2058B (is)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9503545A FR2732340B1 (fr) 1995-03-27 1995-03-27 Nouveaux taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent
FR9515381A FR2742754B1 (fr) 1995-12-22 1995-12-22 Procede de preparation de taxoides
PCT/FR1996/000441 WO1996030356A1 (fr) 1995-03-27 1996-03-25 Nouveaux taxoïdes, leur preparation et les compositions pharmaceutiques qui les contiennent

Publications (2)

Publication Number Publication Date
IS4536A true IS4536A (is) 1997-07-31
IS2058B IS2058B (is) 2005-10-14

Family

ID=26231838

Family Applications (2)

Application Number Title Priority Date Filing Date
IS4536A IS2058B (is) 1995-03-27 1997-07-31 Ný taxóíð, aðferð til framleiðslu þeirra og lyfjasamsetningar sem innihalda þau
IS4567A IS2056B (is) 1995-03-27 1997-09-23 Ný taxóíð, aðferð til að búa þau til og lyfjasamsetningar sem innihalda þau

Family Applications After (1)

Application Number Title Priority Date Filing Date
IS4567A IS2056B (is) 1995-03-27 1997-09-23 Ný taxóíð, aðferð til að búa þau til og lyfjasamsetningar sem innihalda þau

Country Status (41)

Country Link
US (3) US5889043A (is)
EP (2) EP0817780B1 (is)
JP (2) JP3790826B2 (is)
KR (2) KR100485309B1 (is)
CN (2) CN1213042C (is)
AP (2) AP753A (is)
AR (1) AR001440A1 (is)
AT (2) ATE188471T1 (is)
AU (2) AU711227B2 (is)
BG (2) BG63121B1 (is)
BR (2) BR9607929A (is)
CA (2) CA2214319C (is)
CO (1) CO4700576A1 (is)
CZ (2) CZ287326B6 (is)
DE (2) DE69604653T2 (is)
DK (2) DK0817779T3 (is)
DZ (1) DZ2009A1 (is)
EA (2) EA000709B1 (is)
EE (2) EE03608B1 (is)
ES (2) ES2140075T3 (is)
GE (2) GEP20002188B (is)
GR (2) GR3031526T3 (is)
HU (2) HU223666B1 (is)
IL (1) IL117636A (is)
IS (2) IS2058B (is)
MA (1) MA23823A1 (is)
MY (1) MY121225A (is)
NO (2) NO316607B1 (is)
NZ (2) NZ304901A (is)
OA (2) OA10514A (is)
PE (1) PE51097A1 (is)
PL (2) PL188284B1 (is)
PT (1) PT817779E (is)
RO (2) RO115878B1 (is)
SK (2) SK281928B6 (is)
TN (1) TNSN96043A1 (is)
TR (2) TR199701040T1 (is)
TW (1) TW394765B (is)
UY (2) UY24192A1 (is)
WO (2) WO1996030356A1 (is)
ZA (1) ZA962399B (is)

Families Citing this family (77)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6500858B2 (en) 1994-10-28 2002-12-31 The Research Foundation Of The State University Of New York Taxoid anti-tumor agents and pharmaceutical compositions thereof
US6495579B1 (en) 1996-12-02 2002-12-17 Angiotech Pharmaceuticals, Inc. Method for treating multiple sclerosis
US5811452A (en) * 1997-01-08 1998-09-22 The Research Foundation Of State University Of New York Taxoid reversal agents for drug-resistance in cancer chemotherapy and pharmaceutical compositions thereof
US7288665B1 (en) * 1997-08-18 2007-10-30 Florida State University Process for selective derivatization of taxanes
FR2771092B1 (fr) * 1997-11-18 1999-12-17 Rhone Poulenc Rorer Sa Procede de preparation de derives de la classe des taxoides
EP0982027A1 (en) * 1998-08-17 2000-03-01 Aventis Pharma S.A. Taxoid derivatives for treating abnormal cell proliferation of the brain
US6346543B1 (en) * 1998-08-17 2002-02-12 Aventis Pharma S.A. Use of a taxoid to treat abnormal cell proliferation in the brain
JP2002523364A (ja) * 1998-08-20 2002-07-30 アベンテイス・フアルマ・ソシエテ・アノニム タキソイド誘導体の新規な使用
EP0982028A1 (en) * 1998-08-20 2000-03-01 Aventis Pharma S.A. New use of taxoid derivatives
EP1020188A1 (en) * 1999-01-13 2000-07-19 Aventis Pharma S.A. New use of taxoid derivatives
US6649632B2 (en) 2000-02-02 2003-11-18 Fsu Research Foundation, Inc. C10 ester substituted taxanes
HUP0200750A3 (en) * 2000-02-02 2005-02-28 Univ Florida State Res Found C10 heterosubstituted acetate taxanes as antitumor agents and pharmaceutical compositions containing them and their use
AU2001290636A1 (en) * 2000-09-22 2002-04-02 Bristol-Myers Squibb Company Method for reducing toxicity of combined chemotherapies
MXPA03002494A (es) * 2000-09-22 2004-05-24 Bristol Myers Squibb Co Metodo para reducir toxicidad de quimio terapias combinadas.
US6593334B1 (en) 2002-05-02 2003-07-15 The University Of North Carolina At Chapel Hill Camptothecin-taxoid conjugates as antimitotic and antitumor agents
KR101476067B1 (ko) 2002-09-06 2014-12-23 인설트 테라페틱스, 인코퍼레이티드 공유결합된 치료제 전달을 위한 사이클로덱스트린-기초 중합체
US20040122081A1 (en) * 2002-11-08 2004-06-24 Gogate Uday Shankar Pharmaceutical compositions and methods of using taxane derivatives
WO2004103344A1 (en) * 2003-05-20 2004-12-02 Aronex Pharmaceuticals, Inc. Combination chemotherapy comprising a liposomal platinum complex
US7064980B2 (en) * 2003-09-17 2006-06-20 Sandisk Corporation Non-volatile memory and method with bit line coupled compensation
FR2859996B1 (fr) * 2003-09-19 2006-02-03 Aventis Pharma Sa Solvat acetonique du dimethoxy docetaxel et son procede de preparation
GT200500025A (es) * 2004-02-13 2005-09-30 Taxanos sustituidos con esteres de ciclopentilo en c10
PE20050693A1 (es) * 2004-02-13 2005-09-27 Univ Florida State Res Found Taxanos sustituidos con esteres de ciclopentilo en c10
JP2008530122A (ja) * 2005-02-14 2008-08-07 フロリダ・ステイト・ユニバーシティ・リサーチ・ファウンデイション・インコーポレイテッド Ｃ１０シクロプロピルエステル置換タキサン組成物
PL1871753T3 (pl) * 2005-03-31 2012-12-31 Accord Healthcare Inc Wytwarzanie taksanów z 9-dihydro-13-acetylobakatyny iii
EP1948669B1 (en) * 2005-11-04 2013-07-10 Accord Healthcare Inc. New methods for the preparation of taxanes using chiral auxiliaries
US7847111B2 (en) * 2006-06-19 2010-12-07 Canada Inc. Semi-synthetic route for the preparation of paclitaxel, docetaxel, and 10-deacetylbaccatin III from 9-dihydro-13-acetylbaccatin III
WO2008067403A2 (en) * 2006-11-28 2008-06-05 Encore Health Llc Presbyopia treatment by lens alteration
JP2010516625A (ja) 2007-01-24 2010-05-20 インサート セラピューティクス， インコーポレイテッド 制御された薬物送達のためのテザー基を有するポリマー−薬物コンジュゲート
US20100197944A1 (en) * 2007-07-04 2010-08-05 Dr. Reddy's Laboratories Limited Docetaxel process and polymorphs
FR2926551A1 (fr) 2008-01-17 2009-07-24 Aventis Pharma Sa Formes cristallines du dimethoxy docetaxel et leurs procedes de preparation
CA2718567A1 (en) 2008-03-31 2009-12-03 Florida State University Research Foundation, Inc. C(10) ethyl ester and c(10) cyclopropyl ester substituted taxanes
CA2732508C (en) 2008-08-11 2016-03-15 Nektar Therapeutics Multi-arm polymeric alkanoate conjugates
FR2945211A1 (fr) 2009-05-06 2010-11-12 Sanofi Aventis Combinaison antitumorale comprenant la cabazitaxel et la capecitabine
PE20121429A1 (es) 2009-10-29 2012-11-06 Aventis Pharma Sa Nuevo uso antitumoral de cabazitaxel
EP2503888A4 (en) * 2009-11-23 2015-07-29 Cerulean Pharma Inc POLYMERS ON CYCLODEXTRINBASIS FOR THERAPEUTIC ADMINISTRATION
US8791279B2 (en) * 2010-12-13 2014-07-29 Yung Shin Pharm. Ind. Co., Ltd. Process for preparing taxoids from baccatin derivatives using lewis acid catalyst
WO2012088433A1 (en) 2010-12-22 2012-06-28 Nektar Therapeutics Deuterated and/or fluorinated taxane derivatives
US10894087B2 (en) 2010-12-22 2021-01-19 Nektar Therapeutics Multi-arm polymeric prodrug conjugates of cabazitaxel-based compounds
US20130331443A1 (en) 2010-12-22 2013-12-12 Nektar Therapeutics Multi-arm polymeric prodrug conjugates of taxane-based compounds
CN102060815B (zh) * 2010-12-24 2012-09-26 重庆泰濠制药有限公司 一种紫杉烷类化合物的制备方法
EP2491925A1 (en) 2011-02-25 2012-08-29 Aventis Pharma S.A. Antitumoral combination comprising cabazitaxel and cisplatin
EP2620148A1 (en) 2012-01-27 2013-07-31 Aventis Pharma S.A. Antitumoral combination comprising cabazitaxel and cisplatin
LT2678011T (lt) 2011-02-25 2019-12-10 Sanofi Mature Ip Priešnavikinis derinys, apimantis kabazitakselį ir cisplatiną
EP2688877B1 (en) * 2011-04-12 2017-03-08 Teva Pharmaceuticals International GmbH Solid state forms of cabazitaxel and processes for preparation thereof
EP2740477A1 (en) 2011-08-02 2014-06-11 Astellas Pharma Inc. Method for treating cancer by combined use of medicinal agents
TWI526437B (zh) * 2011-09-09 2016-03-21 台灣神隆股份有限公司 卡巴他賽之結晶型
EP2760848B1 (en) * 2011-09-26 2018-11-28 Fresenius Kabi Oncology Limited Processes for the preparation of cabazitaxel involving c(7)-oh and c(13)-oh silylation or just c(7)-oh silylation
CN102336726B (zh) * 2011-09-30 2014-11-26 重庆泰濠制药有限公司 一种卡巴他赛的制备方法
US20130090484A1 (en) * 2011-10-11 2013-04-11 Scinopharm Taiwan Ltd. Process for making an intermediate of cabazitaxel
CN102408397B (zh) 2011-10-19 2014-08-20 上海贝美医药科技有限公司 紫杉烷类衍生物及其制备方法
CN102516281B (zh) * 2011-10-20 2015-02-04 江苏红豆杉生物科技股份有限公司 一种10-脱乙酰基巴卡丁iii及其衍生物甲氧基化的方法
CN102603724B (zh) * 2011-10-20 2014-02-26 江苏红豆杉生物科技股份有限公司 二甲氧基紫杉烷类化合物纯化精制的方法
CN102424672A (zh) * 2011-10-20 2012-04-25 江苏红豆杉生物科技有限公司 脱保护基制备二甲氧基紫杉烷类化合物的方法
WO2013072766A2 (en) * 2011-10-31 2013-05-23 Scinopharm Taiwan, Ltd. Process for cabazitaxel and intermediates thereof
CN102417491B (zh) * 2011-10-31 2013-11-06 江苏红豆杉生物科技有限公司 以10-去乙酰基-巴卡丁iii为原料制备卡巴他赛的方法
DE112012004569T5 (de) * 2011-11-01 2014-08-14 Fresenius Kabi Oncology Ltd. Amorphe Form von Cabazitaxel und Verfahren zum Herstellen davon
CN103159705B (zh) * 2011-12-12 2015-05-27 福建南方制药股份有限公司 卡巴他赛中间体的制备方法
CN102532064B (zh) * 2011-12-13 2015-06-17 重庆泰濠制药有限公司 二甲氧基多西他赛的合成方法
JP6025861B2 (ja) 2011-12-13 2016-11-16 アベンティス・ファーマ・ソシエテ・アノニム カバジタキセルの結晶形およびこれを調製するための方法
EP2880021A4 (en) * 2012-07-31 2015-06-17 Yung Shin Pharm Ind Co Ltd AMORPHIC CABACITAXEL
CN102775435B (zh) * 2012-08-21 2015-04-08 江苏红豆杉生物科技股份有限公司 一种用于制备7,10-甲氧基多西他赛的中间体的合成方法
CN102775434B (zh) * 2012-08-21 2015-04-08 江苏红豆杉生物科技股份有限公司 一种7,10-二甲氧基紫杉烷化合物中间体的合成方法
US20140094432A1 (en) 2012-10-02 2014-04-03 Cerulean Pharma Inc. Methods and systems for polymer precipitation and generation of particles
CN103804323A (zh) * 2012-11-14 2014-05-21 上海希迈医药科技有限公司 一种卡巴他赛溶剂化物及其制备方法和应用
KR101407353B1 (ko) 2012-12-04 2014-06-17 주식회사 삼양바이오팜 10-디아세틸바카틴 iii으로부터 카바지탁셀을 고수율로 제조하는 새로운 방법 및 이를 위한 신규 중간체
EP2743264A1 (en) 2012-12-13 2014-06-18 INDENA S.p.A. New crystalline form of cabazitaxel, process for the preparation and pharmaceutical compositions thereof
EP2815749A1 (en) 2013-06-20 2014-12-24 IP Gesellschaft für Management mbH Solid form of 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione having specified X-ray diffraction pattern
EP2865674A1 (en) 2013-10-23 2015-04-29 INDENA S.p.A. Crystalline solvate forms of Cabazitaxel
EP2865675A1 (en) 2013-10-23 2015-04-29 INDENA S.p.A. A crystalline anhydrous form of Cabazitaxel, process for the preparation and pharmaceutical compositions thereof
CN104650012A (zh) * 2013-11-22 2015-05-27 天士力控股集团有限公司 一种紫杉烷类化合物
CN104086514A (zh) * 2014-06-19 2014-10-08 上海应用技术学院 紫杉醇衍生物及其制备方法
JP6841772B2 (ja) 2015-02-17 2021-03-10 エラスムス・ユニヴァーシティ・メディカル・センター・ロッテルダム 前立腺癌の処置におけるカバジタキセルの使用
EP3093014A1 (en) * 2015-05-13 2016-11-16 Aventis Pharma S.A. Cabazitaxel and its use for treating cancer
WO2020249507A1 (en) 2019-06-11 2020-12-17 Indena S.P.A. Anhydrous crystalline form of cabazitaxel, a process for its preparation and pharmaceutical compositions containing it
CA3148115A1 (en) 2019-08-08 2021-02-11 Laekna Limited Method of treating cancer
EP3797834A1 (en) 2019-09-25 2021-03-31 Sanofi Mature IP Cabazitaxel in mcrpc patients previously treated with docetaxel and who failed a prior androgen signaling targeted inhibitor agent
EP3808345A1 (en) 2019-10-15 2021-04-21 Sanofi Mature IP Cabazitaxel in mcrpc patients previously treated with docetaxel and who failed a prior androgen signaling targeted inhibitor agent

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2629819B1 (fr) 1988-04-06 1990-11-16 Rhone Poulenc Sante Procede de preparation de derives de la baccatine iii et de la desacetyl-10 baccatine iii
MX9102128A (es) 1990-11-23 1992-07-08 Rhone Poulenc Rorer Sa Derivados de taxano,procedimiento para su preparacion y composicion farmaceutica que los contiene
US5489601A (en) 1991-09-23 1996-02-06 Florida State University Taxanes having a pyridyl substituted side-chain and pharmaceutical compositions containing them
US5739362A (en) 1991-09-23 1998-04-14 Florida State University Taxanes having an alkoxy, alkenoxy or aryloxy substituted side-chain and pharmaceutical compositions containing them
US5229526A (en) 1991-09-23 1993-07-20 Florida State University Metal alkoxides
US5319112A (en) 1992-08-18 1994-06-07 Virgnia Tech Intellectual Properties, Inc. Method for the conversion of cephalomannine to taxol and for the preparation of N-acyl analogs of taxol
FR2696459B1 (fr) 1992-10-05 1994-11-25 Rhone Poulenc Rorer Sa Procédé de préparation de dérivés du taxane.
CA2111527C (en) 1992-12-24 2000-07-18 Jerzy Golik Phosphonooxymethyl ethers of taxane derivatives
ZA94128B (en) * 1993-02-01 1994-08-19 Univ New York State Res Found Process for the preparation of taxane derivatives and betalactam intermediates therefor
TW467896B (en) 1993-03-19 2001-12-11 Bristol Myers Squibb Co Novel β-lactams, methods for the preparation of taxanes and sidechain-bearing taxanes
CA2129288C (en) * 1993-08-17 2000-05-16 Jerzy Golik Phosphonooxymethyl esters of taxane derivatives
ATE203016T1 (de) 1993-12-21 2001-07-15 Univ Hawaii Cryptophycine
AU2814595A (en) 1994-06-28 1996-01-25 Pharmacia & Upjohn Company 7-ether-taxol analogs, antineoplastic use and pharmaceutical compositions containing them
US6201140B1 (en) 1994-07-28 2001-03-13 Bristol-Myers Squibb Company 7-0-ethers of taxane derivatives
US5481018A (en) 1995-03-31 1996-01-02 The Dow Chemical Company Amino nitrile intermediate for the preparation of alanine diacetic acid
FR2745814B1 (fr) 1996-03-06 1998-04-03 Rhone Poulenc Rorer Sa Nouveaux taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2771092B1 (fr) 1997-11-18 1999-12-17 Rhone Poulenc Rorer Sa Procede de preparation de derives de la classe des taxoides

Also Published As

Publication number Publication date
DZ2009A1 (fr) 2002-10-23
MA23823A1 (fr) 1996-10-01
IS2058B (is) 2005-10-14
ZA962399B (en) 1996-10-01
EE9700315A (et) 1998-06-15
CZ287468B6 (en) 2000-12-13
AU5278196A (en) 1996-10-16
US20020038038A1 (en) 2002-03-28
BR9607929A (pt) 1998-06-02
MX9706278A (es) 1997-10-31
OA10513A (fr) 2002-04-22
EE03608B1 (et) 2002-02-15
AU703278B2 (en) 1999-03-25
TW394765B (en) 2000-06-21
ES2140075T3 (es) 2000-02-16
KR100485309B1 (ko) 2005-10-12
NO973923L (no) 1997-08-26
HU223732B1 (hu) 2004-12-28
IS2056B (is) 2005-10-14
ES2143187T3 (es) 2000-05-01
EP0817779A1 (fr) 1998-01-14
US5889043A (en) 1999-03-30
BG101917A (en) 1998-10-30
WO1996030355A1 (fr) 1996-10-03
TNSN96043A1 (fr) 2005-03-15
EA199700269A1 (ru) 1998-04-30
AU5278096A (en) 1996-10-16
PE51097A1 (es) 1997-12-22
SK281928B6 (sk) 2001-09-11
CN1152870C (zh) 2004-06-09
GEP20002211B (en) 2000-08-25
HU223666B1 (hu) 2004-11-29
US6387946B1 (en) 2002-05-14
MX9706568A (es) 1997-11-29
DE69606028T2 (de) 2000-08-10
NZ304901A (en) 1998-12-23
PT817779E (pt) 2000-04-28
AP9701090A0 (en) 1997-10-31
NO973923D0 (no) 1997-08-26
AU711227B2 (en) 1999-10-07
AR001440A1 (es) 1997-10-22
NO973922L (no) 1997-08-26
IL117636A (en) 2004-08-31
AP9701093A0 (en) 1997-10-31
EE9700323A (et) 1998-06-15
CZ303297A3 (cs) 1998-01-14
JP3790826B2 (ja) 2006-06-28
RO115878B1 (ro) 2000-07-28
NO316607B1 (no) 2004-03-08
DK0817779T3 (da) 2000-06-19
KR19980703357A (ko) 1998-10-15
HUP9801201A3 (en) 2000-12-28
GR3032316T3 (en) 2000-04-27
CZ287326B6 (en) 2000-10-11
PL188987B1 (pl) 2005-05-31
KR19980703287A (ko) 1998-10-15
SK130297A3 (en) 1998-03-04
DE69604653D1 (de) 1999-11-18
UY24370A1 (es) 2001-10-25
SK281927B6 (sk) 2001-09-11
SK130197A3 (en) 1998-04-08
CN1179776A (zh) 1998-04-22
NO316379B1 (no) 2004-01-19
JP2941951B2 (ja) 1999-08-30
BG101918A (en) 1998-10-30
KR100297196B1 (ko) 2001-11-22
CA2214319C (fr) 2004-02-17
OA10514A (fr) 2002-04-22
ATE188471T1 (de) 2000-01-15
CZ303097A3 (cs) 1998-01-14
TR199701040T1 (xx) 1998-01-21
NZ304900A (en) 1998-09-24
TR199701042T1 (xx) 1998-01-21
DK0817780T3 (da) 2000-03-27
CN1213042C (zh) 2005-08-03
AP785A (en) 1999-11-26
IS4567A (is) 1997-09-23
EA199700270A1 (ru) 1998-02-26
CA2214319A1 (fr) 1996-10-03
PL188284B1 (pl) 2005-01-31
MY121225A (en) 2006-01-28
BG63009B1 (bg) 2001-01-31
EA000567B1 (ru) 1999-12-29
HUP9801204A1 (hu) 2000-05-28
EP0817780A1 (fr) 1998-01-14
RO115877B1 (ro) 2000-07-28
EA000709B1 (ru) 2000-02-28
US6331635B1 (en) 2001-12-18
HUP9801204A3 (en) 2000-12-28
DE69606028D1 (de) 2000-02-10
IL117636A0 (en) 1996-07-23
WO1996030356A1 (fr) 1996-10-03
EP0817779B1 (fr) 2000-01-05
BG63121B1 (bg) 2001-04-30
EP0817780B1 (fr) 1999-10-13
CA2214321A1 (fr) 1996-10-03
ATE185562T1 (de) 1999-10-15
JPH11500141A (ja) 1999-01-06
PL322499A1 (en) 1998-02-02
BR9607930A (pt) 1998-06-02
CN1179775A (zh) 1998-04-22
CO4700576A1 (es) 1998-12-29
GR3031526T3 (en) 2000-01-31
AP753A (en) 1999-07-21
CA2214321C (fr) 2008-01-22
PL322465A1 (en) 1998-02-02
UY24192A1 (es) 1996-06-14
EE03609B1 (et) 2002-02-15
DE69604653T2 (de) 2000-05-31
JPH11502531A (ja) 1999-03-02
NO973922D0 (no) 1997-08-26
HUP9801201A2 (hu) 2000-05-28
GEP20002188B (en) 2000-07-25

Similar Documents

Publication Publication Date Title
IS4536A (is) Ný taxóíð, aðferð til framleiðslu þeirra og lyfjasamsetningar sem innihalda þau
IS4635A (is) 4-fenýlamínóþíasólafleiður, aðferð við að framleiða þær og lyfjablöndur sem innihalda þær
IS5747A (is) Oxazólidínón afleiður, aðferð fyrir framleiðslu þeirra og lyfjasamsetninga sem innihalda þær
NO973479L (no) Substituerte heterosykliske forbindelser, fremgangsmåte for fremstilling og farmasöytiske blandinger inneholdende samme
NO974685D0 (no) Acetamidderivater, fremgangsmåte for fremstilling av disse, og farmasöytisk preparat inneholdende disse
PL345040A1 (en) Novel acyl pseudodipeptides, preparation method and pharmaceutical compositions containing same
IS1947B (is) Setin bensýlamínópíperidín efnasambönd og lyfjablöndur þeirra
HUP9802315A3 (en) Thrombin inhibitors, process for producing them and use of them for producing pharmaceutical compositions
FI973279A0 (fi) Uudet farnesyylitransferaasin inhibiittorit, niiden valmistus ja niitä sisältävät farmaseuttiset koostumukset
ATE180776T1 (de) Naphthylverbindungen, zwischenprodukte, zusammensetzungen und methoden
PL313633A1 (en) Ceramid type compounds, method of obtaining them and their application
PL313070A1 (en) Derivatives of n-(3-benzofuranyl)-urea, method of obtaining them and pharmaceutical compositions containing such derivatives
HRP970130A2 (en) Novel aryl glycinamide derivatives, method of producing said derivatives and pharmaceutical compositions containing these compounds
IS1968B (is) Tilbúnar fjölsykrur, aðferð við að framleiða þær og lyfjablöndur sem innihalda þær
IL117878A0 (en) Taxoids, their preparation and pharmaceutical compositions containing them
PL322310A1 (en) Substances extracted from dictyotales, method of obtaining and compositions containing them
EE9800264A (et) Taksoidid, nende valmistamismeetod ja neid sisaldavad farmatseutilised kompositsioonid
DK0821680T3 (da) Nye taxoider, fremstilling af disse forbindelser og farmaceutiske præparater indeholdende disse forbindelser
PL312693A1 (en) Oxathiolanes, method of their production and pharmaceutical compounds containing them
IS1943B (is) (R)-3-N,N-dísýklóbútýlamínó-8-flúor-3,4-díhýdró-2H-1-bensópýran-5-karboxamíðhýdrógentartrat, aðferðvið framleiðslu þess og lyfjablöndur sem innihalda það
NO975365L (no) Benzopyraner og farmasöytiske sammensetninger inneholdende dem
NO308004B1 (no) Nye aminofenylfosfonsyreforbindelser og farmasøytiske sammensetninger inneholdende dem
EP0747351A3 (en) Thiocationic lipids, pharmaceutical compositions and their methods of use
PL327011A1 (en) Pesticide compounds, compositions and method of obtaining them
DK0806949T3 (da) Ny farmaceutisk komposition, der indeholder trimebutin, og fremgangsmåde til fremstilling deraf